Table of Contents

2020 Month : January Volume : 9 Issue : 1 Page : 1-4

Prostatic FNAC, Evaluation as a Diagnostic Tool and Correlation with Serum Prostate Specific Antigen.

Alka Upreti1, Sanat Kumar Mohanty2

1Department of Pathology, HIMS, Ataria, Sitapur, Uttar Pradesh, India. 2Department of Surgery, South Eastern Coalfield Ltd. India.

References :


Djavan B, Zlotta A, Remzi M, et al. Optimal predictor of prostatic cancer on repeat prostate biopsy: a prospective study of 1,051 men. Journal of Urology 2000;163(4):1144-9.              

Google Scholar | PubMed

Reddy DS, SandhyaRani M. Efficacy of FNAC in early diagnosis of prostatic carcinoma. IAPM 2016;3(10):100-4.              

CrossRef | Google Scholar |

Pantola C, Kala S, Singh PK, et al. A correlative study between transrectal FNAC and histology of the prostate for detection of prostate carcinoma. IOSR Journal of Dental and Medical Science 2012;1(I):18-20.           

CrossRef | Google Scholar |

Sung JC, Kabalin JN, Terris MK. Prostate cancer detection, characterization and clinical outcome in men aged 70yrs and older referred for transrectal ultrasound and prostate biopsies. Urology 2000;56(2):295-301.               

CrossRef | Google Scholar | PubMed

Verma AK, Sharma AK, Bisht D, et al. Role of AGNOR in clinically suspicious prostatic nodule on cytology. Indian Journal of Cytology 2006;23(2):75-8.           

Google Scholar |

Esposti PL. Aspiration biopsy cytology in the diagnosis and management of prostatic carcinoma. Stockholm, Stahl and Accidenstryct 1974.